Stryker Corporation (SYK)vsXtant Medical Holdings Inc (XTNT)
SYK
Stryker Corporation
$327.65
-0.26%
HEALTHCARE · Cap: $125.72B
XTNT
Xtant Medical Holdings Inc
$0.56
+0.55%
HEALTHCARE · Cap: $81.52M
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 18772% more annual revenue ($25.12B vs $133.08M). SYK leads profitability with a 12.9% profit margin vs 1.3%. SYK appears more attractively valued with a PEG of 1.60. SYK earns a higher WallStSmart Score of 65/100 (C+).
SYK
Buy65
out of 100
Grade: C+
XTNT
Hold50
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+16.8%
Fair Value
$393.59
Current Price
$327.65
$65.94 discount
Margin of Safety
-744.3%
Fair Value
$0.07
Current Price
$0.56
$0.49 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 55.9% YoY
Large-cap with strong market position
Strong operational efficiency at 27.2%
Generating 1.9B in free cash flow
Reasonable price relative to book value
19.0% revenue growth
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Weak financial health signals
Expensive relative to growth rate
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 3.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : SYK
The strongest argument for SYK centers on EPS Growth, Market Cap, Operating Margin. Revenue growth of 11.4% demonstrates continued momentum.
Bull Case : XTNT
The strongest argument for XTNT centers on Price/Book, Revenue Growth. Revenue growth of 19.0% demonstrates continued momentum.
Bear Case : SYK
The primary concerns for SYK are PEG Ratio, P/E Ratio, Piotroski F-Score.
Bear Case : XTNT
The primary concerns for XTNT are PEG Ratio, EPS Growth, Market Cap. A P/E of 58.2x leaves little room for execution misses. Thin 1.3% margins leave little buffer for downturns.
Key Dynamics to Monitor
SYK profiles as a value stock while XTNT is a growth play — different risk/reward profiles.
SYK carries more volatility with a beta of 0.87 — expect wider price swings.
XTNT is growing revenue faster at 19.0% — sustainability is the question.
SYK generates stronger free cash flow (1.9B), providing more financial flexibility.
Bottom Line
SYK scores higher overall (65/100 vs 50/100) and 11.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Xtant Medical Holdings Inc
HEALTHCARE · MEDICAL DEVICES · USA
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company is headquartered in Belgrade, Montana.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?